Atticus Advisors

Evaluate a list of Biosimilars for Market entry

A large US pharma wants to evaluate biosimilars in Oncology in India which would establish their presence in the country


Biosimilars of novel targeted molecules play a crucial role in ensuring desirable treatment outcomes with a major benefit for larger masses, particularly in developing countries like India. They greatly reduce the cost of treatment without compromising the efficacy or safety of the treatment.​

As they are increasingly becoming a mainstay in oncology practices, the following case study is about enabling a major American Pharma company to acquire the right biosimilars for the Oncology division in order to provide benefit to Indian patients

Make An Appointment Today

We have an excellent team to give you the best service of caregiving and take care of your loved ones. If you want to explore more about us and give us a chance to get you our finest service, book an appointment today and become a part of our community.